Core Laboratories N.V. (CLB)
NYSE: CLB · IEX Real-Time Price · USD
18.13
+0.09 (0.47%)
May 20, 2024, 11:36 AM EDT - Market open
Core Laboratories Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Core Laboratories stock have an average target of 18.75, with a low estimate of 16 and a high estimate of 21. The average target predicts an increase of 3.45% from the current stock price of 18.13.
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for CLB stock from 4 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 2 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | -0.69% | Apr 26, 2024 |
B of A Securities | B of A Securities | Sell Maintains $17 → $16 | Sell | Maintains | $17 → $16 | -11.72% | Apr 15, 2024 |
Stifel | Stifel | Hold Maintains $21 → $17 | Hold | Maintains | $21 → $17 | -6.21% | Feb 5, 2024 |
Stifel | Stifel | Hold Maintains $23 → $21 | Hold | Maintains | $23 → $21 | +15.86% | Jan 29, 2024 |
Citigroup | Citigroup | Strong Sell Maintains $21 → $20 | Strong Sell | Maintains | $21 → $20 | +10.34% | Sep 18, 2023 |
Financial Forecast
Revenue This Year
596.95M
from 509.79M
Increased by 17.10%
Revenue Next Year
533.71M
from 596.95M
Decreased by -10.59%
EPS This Year
0.88
from 0.78
Increased by 12.60%
EPS Next Year
1.25
from 0.88
Increased by 42.36%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 577.5M | 680.6M | 642.6M | 629.0M | 654.2M |
Avg | 533.7M | 625.8M | 611.6M | 604.5M | 623.7M |
Low | 500.3M | 581.1M | 587.0M | 586.0M | 599.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 13.3% | 27.5% | 2.7% | 2.8% | 8.2% |
Avg | 4.7% | 17.3% | -2.3% | -1.2% | 3.2% |
Low | -1.9% | 8.9% | -6.2% | -4.2% | -0.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.47 | 1.92 | 1.92 | 1.41 | 1.59 |
Avg | 1.25 | 1.63 | 1.61 | 1.32 | 1.51 |
Low | 1.02 | 1.26 | 1.33 | 1.25 | 1.45 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 88.5% | 53.4% | 17.5% | -12.7% | 19.8% |
Avg | 60.3% | 30.8% | -1.5% | -17.9% | 14.1% |
Low | 30.7% | 1.1% | -18.5% | -22.1% | 9.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.